The Street’s Key Stock Analysts Research Reports for 2019

$A, $BIO, $CSIQ, $LNG, $CTAS, $DHR, $DVA, $MYGN, $TEVA

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID 2019 trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Friday as follows:

Agilent Technologies Inc. (NYSE:A) was started with a Buy rating and assigned a 77 price target at Needham. The stock has a consensus target price of 79.33.

Bio-Rad Laboratories Inc. (NYSE:BIO) was raised to Overweight from Equal Weight with a 315 price target at Barclays.

Canadian Solar Inc. (NASDAQ:CSIQ) was raised to Buy from Neutral with a 19 price target at Goldman Sachs.

Cheniere Energy Inc. (NYSEARCA:LNG) was started with a Buy rating and assigned a 72 target price at UBS.

Cintas Corp. (NASDAQ:CTAS) was raised to Buy from Neutral at Merrill Lynch.

Danaher Corp. (NYSE:DHR) was started with a Buy rating and assigned a 114 target price at Needham.

DaVita Inc. (NYSE:DVA) was started with a Buy rating and assigned a 60 target price at Deutsche Bank.

Myriad Genetics Inc. (NASDAQ:MYGN) was started with a Strong Buy rating and assigned a 36 target price at Needham.

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) was raised to Buy from Underperform at Merrill Lynch.

Have a terrific weekend.

The following two tabs change content below.
HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.